Isotype-specific binding patterns of serum antibodies to multiple conformational epitopes of Bet v 1

被引:9
|
作者
Schmalz, Stefanie [1 ]
Mayr, Vanessa [1 ]
Shosherova, Alexandra [1 ]
Gepp, Barbara [1 ,2 ]
Ackerbauer, Daniela [1 ]
Sturm, Gunter [3 ,4 ]
Bohle, Barbara [1 ]
Breiteneder, Heimo [1 ]
Radauer, Christian [1 ]
机构
[1] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria
[2] Univ Appl Sci Technikum Wien, Dept Life Sci Engn, Vienna, Austria
[3] Allergy Outpatient Clin Reumannpl, Vienna, Austria
[4] Med Univ Graz, Dept Dermatol, Graz, Austria
基金
奥地利科学基金会;
关键词
Birch pollen allergy; Bet v 1; conformational epitopes; epitope mapping; BIRCH POLLEN ALLERGEN; MAJOR ALLERGEN; IGE EPITOPES; CROSS-REACTIVITY; PROTEIN; SURFACE; BET-V-1;
D O I
10.1016/j.jaci.2021.10.026
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Birch pollen is an important elicitor of respiratory allergy. The major allergen, Bet v 1, binds IgE exclusively via conformational epitopes. Objective: We identified Bet v 1-specific epitope repertoires of IgE and IgG from birch pollen-allergic and nonallergic subjects. Methods: Chimeric proteins were created by grafting individual epitope-sized, contiguous surface patches of Bet v 1 onto a nonallergenic structural homolog and expressed in Escherichia coli. Binding of IgE, IgG1, and IgG4 from sera of 30 birch pollen-allergic and 11 nonallergic subjects to Bet v 1, 13 chimeric proteins, and 4 bacterial Bet v 1 homologs were measured by ELISA. The proportion of epitope-specific in-total Bet v 1-specific IgE and the cross-reactivity of Bet v 1-specific IgE with bacterial homologs were determined by competitive ELISA. Results: Thirteen soluble, correctly folded chimeric proteins were produced. IgE from 27 of 30 birch pollen-allergic patients bound to 1 to 12 chimeric proteins (median, 4.0), with patientspecific patterns evident. Three chimeras binding IgE from the majority of sera were identified, the grafted patches of which overlapped with previously published epitopes. Patterns of IgG1 and IgG4 binding to the chimeric proteins did not correspond to the binding patterns of IgE. Sera of 19 of 30 birch pollenallergic patients contained low amounts of IgE to bacterial homologs. Bacterial proteins were able to partially inhibit IgE binding to Bet v 1. Conclusion: Epitopes recognized by Bet v 1-specific antibodies from birch pollen-allergic patients are specific to each patient and differ between IgE, IgG1, and IgG4.
引用
收藏
页码:1786 / +
页数:21
相关论文
共 50 条
  • [1] Natural human Bet v 1-specific IgG antibodies recognize non-conformational epitopes whereas IgE reacts with conformational epitopes
    Brazhnikov, Georgii
    Smolnikov, Evgenii
    Litovkina, Alla
    Jiang, Tianchi
    Shatilov, Artem
    Tulaeva, Inna
    Tulaev, Mikhail
    Karaulov, Alexander
    Poroshina, Alina
    Zhernov, Yury
    Focke-Tejkl, Margarete
    Weber, Milena
    Akinfenwa, Oluwatoyin
    Elisyutina, Olga
    Andreev, Sergey
    Shilovskiy, Igor
    Shershakova, Nadezhda
    Smirnov, Valeriy
    Fedenko, Elena
    Lepeshkova, Tatiana Sergeevna
    Beltyukov, Evgeny Cronidovich
    Naumova, Veronika Victorovna
    Kundi, Michael
    Khaitov, Musa
    Wiedermann, Ursula
    Valenta, Rudolf
    Campana, Raffaela
    ALLERGY, 2023, 78 (12) : 3136 - 3153
  • [2] IgE of birch pollen allergic patients recognize conformational epitopes of Bet V 1 whereas IgG antibodies react with non-conformational epitopes
    Brazhnikov, G.
    Smolnikov, E.
    Litovkina, A.
    Campana, R.
    Zhernov, Y.
    Elisyutina, O.
    Fedenko, E.
    Khaitov, M.
    Valenta, R.
    Iliukhina, A. A.
    ALLERGY, 2019, 74 : 220 - 221
  • [4] Mapping of Conformational IgE Epitopes with Peptide-Specific Monoclonal Antibodies Reveals Simultaneous Binding of Different IgE Antibodies to a Surface Patch on the Major Birch Pollen Allergen, Bet v 1
    Gieras, Anna
    Cejka, Petra
    Blatt, Katharina
    Focke-Tejkl, Margarete
    Linhart, Birgit
    Flicker, Sabine
    Stoecklinger, Angelika
    Marth, Katharina
    Drescher, Anja
    Thalhamer, Josef
    Valent, Peter
    Majdic, Otto
    Valenta, Rudolf
    JOURNAL OF IMMUNOLOGY, 2011, 186 (09): : 5333 - 5344
  • [5] ROLE OF ISOTYPE-SPECIFIC AND VP7-SPECIFIC SERUM ANTIBODIES IN PROTECTION AGAINST NATURAL ROTAVIRUS INFECTIONS
    ORYAN, ML
    MATSON, DO
    HERRERA, I
    ESTES, MK
    PICKERING, LK
    PEDIATRIC RESEARCH, 1991, 29 (04) : A181 - A181
  • [6] Large-scale isotype-specific quantification of Serum amyloid A 1/2 by multiple reaction monitoring in crude sera
    Sung, Hye-Jin
    Jeon, Seon-Ae
    Ahn, Jung-Mo
    Seul, Kyung-Jo
    Kim, Jin Young
    Lee, Ju Yeon
    Yoo, Jong Shin
    Lee, Soo-Youn
    Kim, Hojoong
    Cho, Je-Yoel
    JOURNAL OF PROTEOMICS, 2012, 75 (07) : 2170 - 2180
  • [7] Molecular patterns in the isotype-specific antibody responses to the major cedar aeroallergen Jun a 1
    Goldblum, Randall M.
    Madagoda-Desilva, Rumali S.
    Zhang, Yueqing
    van Bavel, Julius
    Midoro-Horiuti, Terumi
    MOLECULAR IMMUNOLOGY, 2018, 101 : 527 - 530
  • [8] ACQUISITION OF SERUM ISOTYPE-SPECIFIC AND G-TYPE-SPECIFIC ANTIROTAVIRUS ANTIBODIES AMONG CHILDREN IN DAY-CARE-CENTERS
    ORYAN, ML
    MATSON, DO
    ESTES, MK
    PICKERING, LK
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (10) : 890 - 895
  • [9] Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1
    Visco, V
    Dolecek, C
    Denepoux, S
    LeMao, J
    Guret, C
    Rousset, F
    Guinnepain, MT
    Kraft, D
    Valenta, R
    Weyer, A
    Banchereau, J
    Lebecque, S
    JOURNAL OF IMMUNOLOGY, 1996, 157 (02): : 956 - 962
  • [10] Targeting immunodominant Bet v 1 epitopes with monoclonal antibodies prevents the birch allergic response
    Atanasio, Amanda
    Franklin, Matthew C.
    Kamat, Vishal
    Hernandez, Annabel Romero
    Badithe, Ashok
    Ben, Li-Hong
    Jones, Jennifer
    Bautista, Joannie
    Yancopoulos, George D.
    Olson, William
    Murphy, Andrew J.
    Sleeman, Matthew A.
    Orengo, Jamie M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (01) : 200 - 211